Literature DB >> 9013597

Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom.

P Marchot1, C N Prowse, J Kanter, S Camp, E J Ackermann, Z Radić, P E Bougis, P Taylor.   

Abstract

Fasciculin, a selective peptidic inhibitor of acetylcholinesterase, is a member of the three-fingered peptide toxin superfamily isolated from snake venoms. The availability of a crystal structure of a fasciculin 2 (Fas2)-acetylcholinesterase complex affords an opportunity to examine in detail the interaction of this toxin with its target site. To this end, we constructed a synthetic fasciculin gene with an appropriate leader peptide for expression and secretion from mammalian cells. Recombinant wild-type Fas2, expressed and amplified in Chinese hamster ovary cells, was purified to homogeneity and found to be identical in composition and biological activities to the venom-derived toxin. Sixteen mutations at positions where the crystal structure of the complex indicates a significant interfacial contact point or determinant of conformation were generated. Two mutants of loop I, T8A/T9A and R11Q, ten mutants of the longest loop II, R24T, K25L, R27W, R28D, H29D, DeltaPro30, P31R, K32G, M33A, and V34A/L35A, and two mutants of loop III, D45K and K51S, were expressed transiently in human embryonic kidney cells. Inhibitory potencies of the Fas2 mutants toward mouse AChE were established, based on titration of the mutants with a polyclonal anti-Fas2 serum. The Arg27, Pro30, and Pro31 mutants each lost two or more orders of magnitude in Fas2 activity, suggesting that this subset of three residues, at the tip of loop II, dominates the loop conformation and interaction of Fas2 with the enzyme. The Arg24, Lys32, and Met33 mutants lost about one order of magnitude, suggesting that these residues make moderate contributions to the strength of the complex, whereas the Lys25, Arg28, Val34-Leu35, Asp45, and Lys51 mutants appeared as active as Fas2. The Thr8-Thr9, Arg11, and His29 mutants showed greater ratios of inhibitory activity to immunochemical titer than Fas2. This may reflect immunodominant determinants in these regions or intramolecular rearrangements in conformation that enhance the interaction. Of the many Fas2 residues that lie at the interface with acetylcholinesterase, only a few appear to provide substantial energetic contributions to the high affinity of the complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013597     DOI: 10.1074/jbc.272.6.3502

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Real-time detection of gene promoter activity: quantitation of toxin gene transcription.

Authors:  K Jeyaseelan; D Ma; A Armugam
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

2.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site.

Authors:  Yves Bourne; Palmer Taylor; Zoran Radić; Pascale Marchot
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

3.  Interaction of synthetic peptides from fasciculin with acetylcholinesterase.

Authors:  R J Falkenstein; C Peña
Journal:  J Protein Chem       Date:  1999-02

4.  Transcriptomic analysis of the venom gland of the red-headed krait (Bungarus flaviceps) using expressed sequence tags.

Authors:  Ang Swee Siang; Robin Doley; Freek J Vonk; R Manjunatha Kini
Journal:  BMC Mol Biol       Date:  2010-03-29       Impact factor: 2.946

5.  Engineering of three-finger fold toxins creates ligands with original pharmacological profiles for muscarinic and adrenergic receptors.

Authors:  Carole Fruchart-Gaillard; Gilles Mourier; Guillaume Blanchet; Laura Vera; Nicolas Gilles; Renée Ménez; Elodie Marcon; Enrico A Stura; Denis Servent
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 6.  Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming.

Authors:  Anjana Silva; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2017-04-19       Impact factor: 4.546

7.  Design, expression and characterization of mutants of fasciculin optimized for interaction with its target, acetylcholinesterase.

Authors:  Oz Sharabi; Yoav Peleg; Efrat Mashiach; Eyal Vardy; Yacov Ashani; Israel Silman; Joel L Sussman; Julia M Shifman
Journal:  Protein Eng Des Sel       Date:  2009-07-30       Impact factor: 1.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.